Table 1.
Cryptococcus neoformans isolate clinical source and typing (n = 30).
| Isolate data | Patient data | ||||
|---|---|---|---|---|---|
| Order | Strain name | WGS cluster | MLST sequence type | Underlying Disease | Sex |
| 1 | BK14 | VNIa-4 | 4 | HIV | M |
| 2 | BK163 | VNIa-4 | 4 | HIV | M |
| 4 | BK225 | VNIa-4 | 4 | HIV | M |
| 6 | BK48 | VNIa-4 | 4 | HIV | M |
| 7 | BK59 | VNIa-4 | 4 | HIV | F |
| 8 | BK69 | VNIa-4 | 4 | HIV | M |
| 9 | BK74 | VNIa-4 | 4 | HIV | M |
| 10 | BK80* | VNIa-4 | 4 | HIV | M |
| 11 | BK87 | VNIa-4 | 4 | HIV | M |
| 12 | BK88 | VNIa-4 | 4 | HIV | M |
| 13 | BK89 | VNIa-4 | 4 | HIV | M |
| 15 | BMD1415* | VNIa-4 | 4 | Lupus | M |
| 3 | BK218 | VNIa-4 | 6 | HIV | M |
| 5 | BK234 | VNIa-4 | 6 | HIV | F |
| 14 | BMD1367* | VNIa-4 | 306 | Gastric cancer | F |
| 16 | BK147* | VNIa-5 | 5 | HIV | M |
| 17 | BK44* | VNIa-5 | 5 | HIV | M |
| 18 | BMD101 | VNIa-5 | 5 | None known | M |
| 19 | BMD1228 | VNIa-5 | 5 | None known | F |
| 20 | BMD1291 | VNIa-5 | 5 | None known | F |
| 21 | BMD1338* | VNIa-5 | 5 | None known | M |
| 22 | BMD1353 | VNIa-5 | 5 | None known | M |
| 23 | BMD1452 | VNIa-5 | 5 | None known | F |
| 24 | BMD1646* | VNIa-5 | 5 | None known | M |
| 25 | BMD1716 | VNIa-5 | 5 | None known | F |
| 26 | BMD367 | VNIa-5 | 5 | None known | M |
| 27 | BMD673 | VNIa-5 | 5 | None known | F |
| 28 | BMD700* | VNIa-5 | 5 | None known | M |
| 29 | BMD854 | VNIa-5 | 5 | None known | F |
| 30 | BMD899 | VNIa-5 | 5 | None known | F |
WGS = whole genome sequencing.
MLST = multi locus sequence typing.
M = Male, F = Female.
* Indicates isolates selected for mouse experiment.